Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
post

Unichem Laboratories Ltd Financial Statements & Historical Data

Updated
Report details
Last Updated:
Author: |Social: XLinkedIn

Unichem Laboratories Ltd: For the quarter ending Jun 2026, reported sales were ₹633 crore and the net profit was ₹41 crore. This compares with a loss of ₹10 crore in Jun 2025, marking a return to reported profit. Operating margin eased to 8.6% in Mar 2026.

Calculated from the stored statements below · Reporting periods remain separate
COMPANY FINANCIAL DATA

Reported figures at a glance

Stored figures, not live quotes. Price record: 9 October 2026, 9:48 pm +05:30. Financial reporting periods are shown in the tables below.

Stored share price531₹ per share
Reported P/E30.7Times
Book value per share386₹ per share
Reported ROCE4.13 %%
Data sources and reporting basis

Sources: Company data source. Check the company filings linked by the source for the reporting basis and exceptional items.

Different tables can have different reporting dates and accounting bases. Verify the company filings before comparing figures. Missing data is not treated as zero.

How Getaka handles sources, dates and corrections. Page revision dates describe the page, not the age of every financial figure.

Stored market and accounting figures

Price record: 9 October 2026, 9:48 pm +05:30. Not a live quote.

MeasureStored figure
Market Cap3,752 Cr.
Current Price531
High / Low687/278
Stock P/E30.7
Book Value386
Dividend Yield0.00 %
ROCE4.13 %
ROE3.17 %
Face Value2.00

Market cap is in ₹ crore; prices and per-share values are in ₹. P/E is a multiple; yield, ROCE and ROE are percentages. Book value is an accounting figure, not an estimate of the share's investment value.

FINANCIALS

Quarterly performance

For the quarter ending Jun 2026, reported sales were ₹633 crore and the net profit was ₹41 crore. This compares with a loss of ₹10 crore in Jun 2025, marking a return to reported profit. Operating margin was 11.1%, 6.9 percentage points higher than Jun 2025. The business retained more operating profit from each rupee of sales; check whether the change persists across periods.

Sales, expenses & profits

₹ crore

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods
Supporting financial tableAll reported figures · use a chart icon for peer comparison

Quarterly Chart Table

MetricJun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales 423416466432483507533587527579521575633
Expenses 395407435406443452448503504513476527563
Operating Profit 2893125405586842266454870
OPM % 7%2.1%7%6%8%11%16%14%4.3%11%9%8%11%
Other Income 9679-119491497-372871116
Interest 6765457578797
Depreciation 29293227323231303231313130
Profit before tax 2-2273-1268276258-9-112931949
Tax % 132%12%-0%3%74%9%6%8%16%10%10%42%15%
Net Profit -1-2473-1292255853-10-122641141
EPS in Rs -0.10-3.4810.40-18.370.293.508.227.52-1.49-1.6937.541.555.89

Last Updated: September 29, 2026, 4:57 pm

FINANCIALS

Annual performance

For the year ending Mar 2026, reported sales were ₹2,202 crore and the net profit was ₹253 crore. Sales rose 4.3% and profit rose 83.3% against Mar 2025. Operating margin was 8.6%, 4.0 percentage points lower than Mar 2025. The business retained less operating profit from each rupee of sales; review the expense mix in the statement.

Sales, expenses & profits

₹ crore

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods

Earnings per share

₹ per share

Hover or tap the chart for dated values.

Chart loads as you scroll. Values are available in the table.

All reported periods
Supporting financial tableAll reported figures · use a chart icon for peer comparison

Profit & Loss Chart Table

Last Updated: October 12, 2026, 4:53 am

MetricMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales 1,2021,3336988151,1801,1041,2351,2701,3431,7852,1112,2022,308
Expenses 1,1001,1697389421,2541,1531,1441,1981,3891,6981,8462,0132,079
Operating Profit 101164-41-128-74-499172-4687265189229
OPM % 8%12%-6%-16%-6%-4.5%7%6%-3.4%4.9%13%9%10%
Other Income 20151842,73591915047-0-2635260277
Interest 333888561723213232
Depreciation 4139445167828491113123125125123
Profit before tax 77137972,548-58-485122-176-85155292350
Tax % 3%21%-12%0%-59%25%33%-50%15%10%11%14%
Net Profit 751081092,545-24-603433-202-94138253305
EPS in Rs 8.3111.9011.96361.82-3.38-8.554.874.70-28.72-13.3219.5335.9143.29
Dividend Payout % 24%17%25%1%-118%-47%82%85%-14%0%0%0%

YoY Net Profit Growth

Year2015-20162016-20172017-20182018-20192019-20202020-20212021-20222022-20232023-20242024-20252025-2026
YoY Net Profit Growth (%)44.00%0.93%2234.86%-100.94%-150.00%156.67%-2.94%-712.12%53.47%246.81%83.33%
Change in YoY Net Profit Growth (%)0.00%-43.07%2233.94%-2335.81%-49.06%306.67%-159.61%-709.18%765.59%193.34%-163.48%

Growth

Compounded Sales Growth
10 Years:6%
5 Years:14%
3 Years:18%
TTM:20%
Compounded Profit Growth
10 Years:6%
5 Years:29%
3 Years:63%
TTM:651%
Stock Price CAGR
10 Years:7%
5 Years:15%
3 Years:12%
1 Year:-13%
Return on Equity
10 Years:12%
5 Years:0%
3 Years:-1%
Last Year:6%

Last Updated: September 5, 2025, 1:50 pm

FINANCIALS

Balance sheet

Reported borrowings stood at ₹500 crore in Mar 2026. They increased from ₹460 crore in Mar 2025 (8.7% higher). Read the borrowing notes, repayment schedule and cash-flow statement together; the borrowing balance alone does not establish liquidity or repayment capacity.

Reserves & borrowings

₹ crore

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods
Supporting financial tableAll reported figures · use a chart icon for peer comparison

Balance Sheet Data Table

Last Updated: July 27, 2026, 3:00 am

MonthMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital 181818141414141414141414
Reserves 8499361,0452,6662,6062,5172,5432,6042,4212,4242,4372,703
Borrowings 223698151200206119349314248460500
Other Liabilities 264283359359323407436351444589659489
Total Liabilities 1,1531,2741,5213,1903,1423,1453,1123,3193,1933,2753,5693,707
Fixed Assets 4164034915788108708849901,2571,2521,3001,213
CWIP 1232372502389233056849414712331100
Investments 4114149019265503922642100
Other Assets 5746207661,4731,3131,3951,2691,5711,7871,8982,2392,394
Total Assets 1,1531,2741,5213,1903,1423,1453,1123,3193,1933,2753,5693,707
FINANCIALS

Cash generation

Operating activities generated ₹4.00 crore in Mar 2026. Reported free cash flow for the same period was ₹163 crore. Positive operating cash flow shows cash generated by operations in this period; examine its consistency and the capital expenditure needed to sustain the business.

Operating & free cash flow

₹ crore

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods
Supporting financial tableAll reported figures · use a chart icon for peer comparison

Cash Flows

MonthMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity + 7811268-112-3282033-260-8514-74
Cash from Investing Activity + -52-85-1321,648-286-36-6610024163-242194
Cash from Financing Activity + -51-3359-881-2-62-121191-81-1061842
Net Cash Flow -25-7-4655-616-78-1543275-29-65200
Free Cash Flow 4-28-79-271-519-360-254-386-1230-142163
CFO/OP 95%87%-237%89%424%-49%52%-350%160%23%4%6%
Free cash flowAll reported figures · use a chart icon for peer comparison

Free Cash Flow Table

Free cash flow reported in the stored cash-flow statement (₹ Cr)
PeriodMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Free Cash Flow4.00-28.00-79.00-271.00-519.00-360.00-254.00-386.00-123.000.00-142.00163.00

This table and the chart use the Free Cash Flow row from the same stored cash-flow statement. Free cash flow generally measures operating cash flow after capital expenditure; check the source definition and reporting basis. It is not operating profit minus borrowings.

Financial efficiency feed. Source: www.screener.in. The source URL identifies consolidated accounts. Values from separate feeds can differ, even for the same period; they are not interchangeable. Use each table’s period labels. Data methodology.

FINANCIALS

Financial & business efficiency

Working-capital days were 159 in Mar 2025. That is 14 days lower than the same annual period a year earlier. Compare collection, inventory and payment cycles within this feed to understand the movement; these measures do not identify the cause by themselves.

Working capital

Days

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods

Returns on capital & equity

%

Hover or tap the chart for dated values.

Chart loads as you scroll. Values are available in the table.

All reported periods
Supporting financial tableAll reported figures · use a chart icon for peer comparison

Financial Efficiency Data Table

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Debtor Days 63586016512413512974142160131135
Inventory Days 192171184397278278374518527414365418
Days Payable 142114131297230182236202161193174170
Cash Conversion Cycle 113116113265172231267390508382322382
Working Capital Days 948890174133165154163207207173159
ROCE %19%9%15%9%128%-2%-2%2%1%-5%-0%6%
FINANCIALS

Ownership trends

Promoters held 70.22% in Jun 2026. Their share was unchanged from Jun 2025. Ownership percentages can change through share issuance as well as transactions. Check exchange disclosures for the explanation and any pledging; the percentage alone is not evidence of investor conviction.

Shareholding comparison

%

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods

Shareholder count

Shareholders

Hover or tap the chart for dated values.

Chart loads as you scroll. Values are available in the table.

All reported periods
Supporting financial tableAll reported figures · use a chart icon for peer comparison

Shareholding Pattern

MonthSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Promoters 70.21%70.22%70.22%70.22%70.22%70.22%70.22%70.22%70.22%70.22%70.22%70.22%
FIIs 0.83%0.84%0.90%0.89%0.94%1.05%0.98%0.98%0.99%0.99%1.00%0.90%
DIIs 10.00%10.46%11.26%11.57%11.65%11.63%11.32%10.92%10.74%10.73%10.63%10.46%
Public 18.95%18.47%17.63%17.32%17.17%17.11%17.47%17.88%18.04%18.05%18.14%18.41%
No. of Shareholders 21,58420,87721,17120,62120,37421,47221,62123,01023,57723,26723,38625,347
Mutual fund holdingsReported fund ownership · Expand table

Mutual Fund Holdings Data Table

Fund NameNo of SharesAUM (%)Amount Invested (Cr)Previous Number of SharesPrevious DatePercentage Change
DSP Healthcare Fund 852,063 1.06 33.24735,5912025-11-03 09:45:1515.83%

Alternate ratio feed. Source: www.way2wealth.com. The accounting basis and ratio definitions require verification against the source. Values from separate feeds can differ, even for the same period; they are not interchangeable. Use each table’s period labels. Data methodology.

FINANCIALS

Ratios from the alternate data feed

Related measures share a chart and a common unit. Use the dated figures below to examine any change.

Profitability ratios

%

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods

Liquidity ratios

Multiple (×)

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods

Distributions & retention

%

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods

Interest coverage

Multiple (×)

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods

Valuation multiples

Multiple (×)

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods
Supporting financial tableAll reported figures · use a chart icon for peer comparison

Key Financial Ratios

MonthMar 25Mar 24Mar 23Mar 22Mar 21
FaceValue 2.002.002.002.002.00
Basic EPS (Rs.) 19.53-10.01-28.724.704.88
Diluted EPS (Rs.) 19.53-10.01-28.724.704.88
Cash EPS (Rs.) 37.236.07-7.1317.8016.91
Book Value[Excl.RevalReserv]/Share (Rs.) 348.10335.54345.89371.90363.16
Book Value[Incl.RevalReserv]/Share (Rs.) 348.10335.54345.89371.90363.16
Revenue From Operations / Share (Rs.) 299.85242.15190.75180.36175.43
PBDIT / Share (Rs.) 42.6418.73-0.9917.0920.07
PBIT / Share (Rs.) 24.952.64-17.114.148.09
PBT / Share (Rs.) 21.96-8.76-19.573.277.36
Net Profit / Share (Rs.) 19.53-10.01-23.254.854.92
NP After MI And SOA / Share (Rs.) 19.53-10.01-28.724.704.88
PBDIT Margin (%) 14.227.73-0.529.4711.43
PBIT Margin (%) 8.311.09-8.972.294.61
PBT Margin (%) 7.32-3.61-10.261.814.19
Net Profit Margin (%) 6.51-4.13-12.182.682.80
NP After MI And SOA Margin (%) 6.51-4.13-15.052.602.77
Return on Networth / Equity (%) 5.61-2.98-8.301.261.34
Return on Capital Employeed (%) 6.810.75-4.711.052.17
Return On Assets (%) 3.85-2.22-6.330.991.09
Long Term Debt / Equity (X) 0.020.010.020.030.00
Total Debt / Equity (X) 0.170.090.120.120.03
Asset Turnover Ratio (%) 0.620.530.410.300.35
Current Ratio (X) 2.052.402.492.992.72
Quick Ratio (X) 1.061.401.511.901.66
Inventory Turnover Ratio (X) 2.491.120.860.871.15
Dividend Payout Ratio (NP) (%) 0.000.000.0085.1882.04
Dividend Payout Ratio (CP) (%) 0.000.000.0022.6623.72
Earning Retention Ratio (%) 0.000.000.0014.8217.96
Cash Earning Retention Ratio (%) 0.000.000.0077.3476.28
Interest Coverage Ratio (X) 14.275.82-0.4019.7027.60
Interest Coverage Ratio (Post Tax) (X) 7.540.43-8.456.597.77
Enterprise Value (Cr.) 5189.653504.162147.122049.282195.83
EV / Net Operating Revenue (X) 2.462.061.601.611.78
EV / EBITDA (X) 17.2926.58-304.9717.0315.54
MarketCap / Net Operating Revenue (X) 2.312.021.521.441.76
Retention Ratios (%) 0.000.000.0014.8117.95
Price / BV (X) 1.991.460.830.700.85
Price / Net Operating Revenue (X) 2.312.021.521.441.76
EarningsYield 0.02-0.02-0.090.010.01

Competitors

Stock Name ⇩Market Cap ⇩Current Price ⇩High / Low ⇩Stock P/E ⇩Book Value ⇩Dividend Yield ⇩ROCE ⇩ROE ⇩Face Value ⇩
Unichem Laboratories Ltd 3,752 Cr. 531 687/27830.7 3860.00 %4.13 %3.17 % 2.00
Aarti Drugs Limited 3,763 Cr. 413 534/31921.8 1540.48 %11.7 %12.7 % 10.0
Kwality Pharmaceuticals Ltd 3,702 Cr. 3,564 3,949/82945.3 3210.00 %23.9 %22.5 % 10.0
Gufic BioSciences Ltd 4,080 Cr. 406 468/26855.5 66.20.02 %12.2 %9.98 % 1.00
SMS Pharmaceuticals Ltd 4,163 Cr. 445 494/26946.0 85.90.09 %12.9 %11.9 % 1.00
Industry Average17,127.26 Cr1,216.6253.25211.240.40%26.16%16.59%6.06

All Competitor Stocks of Unichem Laboratories Ltd

Explore Industry-wise Company financial data